Cite

HARVARD Citation

    Adeyeye, E. et al. (2023). Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF). Drug and therapeutics bulletin. 61 (2), pp. 22-23. [Online]. 
  
Back to record